Detalles de la búsqueda
1.
Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT).
Cytotherapy
; 2024 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38416085
2.
Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?
Int J Mol Sci
; 23(9)2022 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35563245
3.
COVID-19-associated oxidative damage to red blood cells.
Br J Haematol
; 193(3): 481, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33427300
4.
Thrombocytopenia as an initial manifestation of COVID-19; case series and literature review.
Br J Haematol
; 189(6): 1057-1058, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32369609
5.
COVID-19 in bone marrow transplant recipients: reflecting on a single centre experience.
Br J Haematol
; 190(2): e67-e70, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32469077
6.
Non-Graft-versus-Host Disease Enterocolitis Following Cord Blood Transplantation is Real, with Poorly Understood Pathophysiology, and Requires Distinct Management, with Eventual Resolution without Immune Suppression.
Transplant Cell Ther
; 30(4): 440.e1-440.e9, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38052367
7.
A retrospective cohort study of Libmeldy (atidarsagene autotemcel) for MLD: What we have accomplished and what opportunities lie ahead.
JIMD Rep
; 64(5): 346-352, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37701322
8.
T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancy.
Blood Adv
; 7(10): 2155-2165, 2023 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36649566
9.
Management of Allogeneic Stem Cell Transplantation for High-Risk AML following SARS-CoV-2 Associated Pancytopenia with Marked Bone Marrow Biopsy Alterations.
Case Rep Hematol
; 2021: 8843063, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33510919
10.
Autoimmune Cytopenias Developing Late Post Alemtuzumab-Based Allogeneic Stem Cell Transplantation: Presentation of Short Case Series from a Transplant Center.
Cell Transplant
; 29: 963689720950641, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32806929
11.
First case of near haploid philadelphia negative B-Cell acute lymphoblastic leukaemia relapsing as acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.
Leuk Res Rep
; 14: 100213, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32612922
12.
A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant.
Hematol Rep
; 11(1): 7800, 2019 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30915202
13.
Recognising inequalities in haematopoietic stem-cell transplantation and cellular therapy training.
Lancet Haematol
; 9(5): e323-e324, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35313128
14.
ERRATUM: A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant.
Hematol Rep
; 12(2): 8995, 2020 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33282167
15.
Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic hematopoietic stem cell transplantation.
Leuk Lymphoma
; 61(1): 202-205, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31402762
16.
Reduced intensity alemtuzumab-containing allogeneic stem cell transplantation for relapsed/refractory low grade lymphoma: reflections on a single center experience.
Leuk Lymphoma
; 60(12): 3075-3077, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31079514
Resultados
1 -
16
de 16
1
Próxima >
>>